
Monthly Subscription
60 mL · 30-day supply
- 1 mL once daily
- Automatic monthly refill
- Cancel anytime

Three prescription actives. One topical foam. Once daily.
Minoxidil 7% · Finasteride 0.1% · Tretinoin 0.025% · 60 mL
Starting this treatment? We’ll guide you through the health questions. Already approved? Choose your next quantity without starting over.
If you need new approval, we'll guide you through the questions before your order can ship.
01One 30-day foam bottleThe quick-dry 60 mL foam combines all three actives in one once-daily prescription step.
02Follicle support from three directionsMinoxidil supports the growth phase, finasteride reduces local DHT formation, and tretinoin supports turnover and penetration. The exact combination has not been independently proven to guarantee superior outcomes.
03A routine designed for consistencyDaily topical use can reduce the friction of managing separate products, while provider follow-up keeps side effects and expectations in view.
RegrowPro FoamThree actives in one topicalDo not combine RegrowPro with oral finasteride, dutasteride, oral minoxidil, or another scalp treatment unless the prescriber explicitly approves it.
Consistency without certainty
A strong formula cannot promise regrowth. Hair biology, diagnosis, stage, adherence, health, and time all shape the outcome.
Start with diagnosis and screening
A licensed provider reviews scalp photos, pregnancy and conception risks, cardiovascular history, prior finasteride effects, and other treatments.
RegrowPro is a compounded prescription foam containing minoxidil 7%, finasteride 0.1%, and tretinoin 0.025%. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness, or quality before marketing. Do not use if pregnant, planning pregnancy within 12 months, trying to conceive, breastfeeding, under 18, allergic to an ingredient, or on broken, infected, inflamed, or severely diseased scalp. Women who may become pregnant require documented effective contraception and provider approval. Finasteride can cause abnormalities in a male fetus. Female partners who may become pregnant should avoid direct contact with treated scalp for at least four hours. Men actively trying to conceive require provider review. Do not combine with oral finasteride or dutasteride without explicit direction. Topical finasteride has lower systemic exposure than oral dosing but exposure is not zero; sexual, mood, breast, fertility, and persistent post-discontinuation symptoms have been reported with finasteride. Systemic minoxidil absorption can cause dizziness, low blood pressure, rapid heartbeat, swelling, fluid retention, chest discomfort, or headache; disclose cardiovascular disease and blood-pressure medicines. Tretinoin can cause redness, peeling, burning, dryness, and sun sensitivity. Initial shedding during weeks 2–8 can occur. Stop and seek urgent care for chest pain, trouble breathing, fainting, marked swelling, severe heartbeat changes, facial/throat swelling, or severe rash. Apply 1 mL once daily to dry affected scalp, leave at least four hours, wash hands, avoid eyes/face, heat/flame until dry, and do not exceed the prescribed amount. Store at room temperature away from sunlight. Follow the pharmacy-labeled 180-day BUD. Results vary; no regrowth, density, volume, sexual-safety, or side-effect-free outcome is guaranteed.